Biological E. to begin Phase III trial of COVID-19 vaccine
The company plans to produce 75 million to 80 million doses a month from August
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Baylor College of Medicine
Biological E signs tech transfer pacts with Baylor College of Medicine and J&J for COVID-19…
The agreements are for Baylor's recombinant protein vaccine candidate and J&J's Ad26.COV2.S vaccine, currently in Phase 1/2…
Merck and Baylor College of Medicine sign agreement for R&D in neglected diseases
The collaboration includes training and exchange of technical know-how in process development and formulation, filling knowledge…